Understanding Heme Oxygenase-1 (HO-1) Deficiency

Receiving a diagnosis of Heme Oxygenase-1 (HO-1) deficiency can feel overwhelming, especially because it is one of the rarest genetic conditions in the world ^[1]. Because fewer than 20 cases have ever been published in medical literature, it is very likely that your local doctors and specialists have never encountered it before ^[1][2]. This page is designed to help you understand the core biology of this condition and why it affects so many different systems in the body. While the language here often addresses parents of a child, the condition can also affect adults, and the core biology remains the same.

What is HO-1 Deficiency?

HO-1 deficiency is an autosomal recessive genetic disorder, meaning a person must inherit two changed (mutated) copies of the HMOX1 gene—one from each parent—to be affected ^[3][4]. (If both parents are carriers, there is a 25% chance with each pregnancy of having an affected child, making genetic counseling helpful for family planning.)

The HMOX1 gene is responsible for producing an enzyme called heme oxygenase-1 (HO-1). This enzyme acts as a master recycler and protector for the body ^[5]. Its primary job is to break down heme—a component of the hemoglobin that carries oxygen in your red blood cells—when those cells reach the end of their lifespan ^[6].

The Biology of “Recycling” Heme

In a typical body, the HO-1 enzyme breaks heme down into three essential parts:

1. Iron: Which is recycled to make new red blood cells ^[5].
2. Carbon Monoxide: Which, in very tiny amounts, helps protect blood vessels and calm inflammation ^[5].
3. Biliverdin: Which is quickly converted into bilirubin by another enzyme called biliverdin reductase (bilirubin is the substance that usually causes jaundice or yellowing of the skin) ^[6].

When the HO-1 enzyme is missing or not working correctly, this recycling process stops. This leads to two major problems:

• Impaired Handling and Buildup: Instead of being recycled smoothly, raw heme and iron can accumulate inside cells and organs ^[7]. This can be “toxic,” causing damage to the kidneys, liver, lungs, and blood vessels ^[3][4].
• The “Low Bilirubin” Paradox: Normally, when red blood cells break down quickly (hemolysis), a person develops high bilirubin and jaundice. In HO-1 deficiency, because the engine that creates biliverdin is broken, bilirubin levels often remain unusually low or normal even when red blood cells are being destroyed ^[3][8].

A Multisystem and Variable Condition

HO-1 deficiency is a multisystem disorder, meaning it can affect many different parts of the body at once. Because the enzyme is also involved in controlling inflammation, patients are at risk for “flares” where the immune system becomes overactive, often triggered by a simple infection ^[3][2].

The way the condition appears can vary significantly between individuals:

• Age of Onset: Some children show severe symptoms as early as 17 months old, while other cases have not been identified until adulthood (around age 30) ^[4][1].
• Symptom Severity: Some patients may have severe lung or heart complications, while others may primarily struggle with kidney issues or persistent anemia ^[3][8][4].

Because the condition is so rare, researchers are still learning why it looks so different from one person to the next. Finding a care team that is willing to collaborate with international experts is often the most important step for families navigating this ultra-rare journey.